Concepedia

Publication | Closed Access

Effects of monthly intramuscular neridronate in rheumatic patients in chronic treatment with low-dose glucocorticoids.

13

Citations

29

References

2009

Year

Abstract

A twelve-month intramuscular NE treatment in rheumatic patients under GCs therapy improves lumbar and femoral BMD and mainly reduces the markers of bone resorption.

References

YearCitations

Page 1